6-aminonicotinamide has been researched along with Central Nervous System Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Penkowa, M | 1 |
| Horita, N; Ishii, T; Izumiyama, Y | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Cervos-Navarro, J; Knoll-Köhler, E; Sarkander, HI | 1 |
1 review(s) available for 6-aminonicotinamide and Central Nervous System Disease
| Article | Year |
|---|---|
Metallothionein I + II expression and roles during neuropathology in the CNS.
Topics: 6-Aminonicotinamide; Animals; Brain; Brain Diseases; Brain Injuries; Central Nervous System; Central Nervous System Diseases; DNA Fragmentation; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation Mediators; Lymphocyte Activation; Macrophages; Metallothionein; Necrosis; Neovascularization, Pathologic; Neurofibrillary Tangles; Oxidative Stress; Tumor Necrosis Factor-alpha | 2006 |
3 other study(ies) available for 6-aminonicotinamide and Central Nervous System Disease
| Article | Year |
|---|---|
Ultrastructure of 6-aminonicotinamide (6-AN)-induced lesions in the central nervous system of rats. II. Alterations of the nervous susceptibility with aging.
Topics: 6-Aminonicotinamide; Aging; Animals; Brain Stem; Central Nervous System; Central Nervous System Diseases; Cerebral Cortex; Corpus Striatum; Creutzfeldt-Jakob Syndrome; Humans; Limbic System; Male; Neurons; Niacinamide; Pellagra; Rats; Spinal Cord | 1980 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.
Topics: 6-Aminonicotinamide; Animals; Brain; Central Nervous System Diseases; Depression, Chemical; Electrophoresis; Female; Histones; Neuroglia; Niacinamide; Rats; RNA; Transcription, Genetic | 1978 |